Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Fructo-Oligosaccharides (FOS) are prebiotic fibers found naturally in many plants. Their use to support or treat metabolic syndrome is primarily supported by emerging scientific evidence, rather than by tradition. FOS are not historically used in traditional medicine systems for this purpose. Instead, their role has been explored in recent decades due to their impact on gut microbiota, which in turn may influence metabolic health.

Several studies, including randomized controlled trials and animal research, have demonstrated that FOS supplementation can beneficially modulate the composition of gut microbiota by promoting the growth of beneficial bacteria such as Bifidobacterium and Lactobacillus. These microbial changes have been linked with improved metabolic parameters, including better glucose tolerance, reduced fasting blood glucose, improved insulin sensitivity, and, in some cases, modest reductions in body weight or visceral fat. Some human studies have reported improvements in lipid profiles and reductions in low-grade inflammation, both of which are relevant to metabolic syndrome.

However, while the mechanistic rationale and early results are promising, the overall quality and size of human clinical trials are still limited. Effects observed are generally modest, and not all studies report significant benefits. Therefore, FOS's use for metabolic syndrome is considered scientifically plausible and supported by preliminary evidence, but more large-scale, long-term human trials are needed to confirm clinically meaningful effects.

More about Fructo-Oligosaccharides (FOS)
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Fructo-Oligosaccharides (FOS)

Products containing Fructo-Oligosaccharides (FOS)